Developing World / LMICs
While Cures Within Reach is disease-agnostic and geography-agnostic, some of our funding partners have strategic interests in specific geographic regions. Therefore, in addition to our disease-specific repurposing communities, we work to increase the repurposing research focused on improving the quality and length of life within the Developing World, specifically low and low-middle income countries (LMICs, as defined by the World Bank) through the speed and cost-effectiveness of medical repurposing.
Our events and research within the the Developing World Repurposing Community all focus on connecting our many stakeholder groups together in our shared goal: driving more treatments to more patients more quickly through repurposing.
Read our news release from April 21, 2022 here, describing the 10 DEI clinical trials recently selected, including 3 in LMICs!
Our ongoing LMIC trials:
Open Funding Opportunity for the Developing World / LMICs:
ReGRoW: Repurposing Grants for the Rest of the World – Funding for Underserved Researchers in Low and Lower-Middle Income Countries (LMICs): budgets of up to US$60,000 for clinical repurposing trials in any disease led by underserved researchers in any LMIC (as defined by the World Bank). CLOSED; SUBMISSIONS UNDER REVIEW.
More information on our Funding Opportunities / RFPs page.
Three Trials from our 2022 RFP, ongoing now:
- Dr. Dinesh Mondal at International Centre for Diarrhoeal Disease Research, Bangladesh: Assessing Safety and Efficacy of Oral Ivermectin in Post Kala-Azar Dermal Leishmaniasis Treatment
- Dr. Stanley Zimba at University of Zambia School of Medicine: Testing an Antihypertensive Drug as an Add-On therapy for Drug-Resistant Epilepsy Patients in Zambia
- Dr. Fahafahantsoa Rapelanoro Rabenja at University of Antananarivo: Effect of methotrexate as a treatment for moderate to severe atopic dermatitis in Madagascar
Three Trials Funded in 2021, ongoing now:
- For chronic pancreatitis patients in India
- For triple negative breast cancer in Nigeria
- In pediatric chronic ear infections in Nigeria
Three Trials Based in LMICs Funded in 2020, 2 ongoing now, 1 completed:
Dr. Hamaluba researching snakebites in Kenya
Dr. Nguyen researching a rare pediatric liver disease biliary atresia in Vietnam
COMPLETED: Dr. Adewole researching tuberculosis in Nigeria
Diversity of Clinical Trial Researchers and Patients: A Repurposing Opportunity?
A dialogue on the dual opportunities of clinical trial diversity to impact health disparities and/or improve minority leadership in scientific research.
Real World Data Through a Patient’s Lens
A conversation on Real World Data (RWD) and case reports from clinicians and researchers.
Repurposing for Pediatric Patients: Best Practices and Lessons Learned
A patient-focused conversation on the opportunities that repurposing drugs, devices and other treatments provide for the pediatric patient population.
How Patients Impact the 505(b)(2) Regulatory Process
A patient-focused conversation on the 505(b)(2) regulatory process and how patients, caregivers and patient advocacy groups can engage with both industry and regulators to support the drug development process, share their real-world perspectives for clinical trial planning and represent the patient view throughout the drug approval process.
CureAccelerator Live! for the Developing World 2019
Five finalists from the US and India competing for up to $50,000 to fund their repurposing clinical trials impacting patients in the Developing World.
Current Developing World Research Projects
Completed Developing World Research Projects
(in the past 3 years)